NS 102

• CAT Number: M132014
• CAS Number: 136623-01-3
• Molecular Formula: C12H11N3O4
• Molecular Weight: 261.23
• Purity: ≥95%
• Target: Neuronal Signaling
• Storage: -20°C
• IUPAC Name: 5-nitro-3-nitroso-6,7,8,9-tetrahydro-1H-benzo[g]indol-2-ol
• InChI: InChI=1S/C12H11N3O4/c16-12-11(14-17)8-5-9(15(18)19)6-3-1-2-4-7(6)10(8)13-12/h5,13,16H,1-4H2
• InChIKey: SADZJARZJNQZHT-UHFFFAOYSA-N
• SMILES: C1CCC2=C3C(=CC(=C2C1)[N+](=O)[O-])C(=C(N3)O)N=O

NS 102（Cat No.:M132014）, a potential treatment for Alzheimer’s disease, is a small molecule that targets tau protein aggregation, a hallmark of the disease. It has shown promise in preclinical studies by reducing tau aggregation and improving cognitive function in animal models. NS 102’s mechanism involves binding to tau and inhibiting its aggregation, potentially slowing disease progression. This compound has demonstrated good safety profiles in studies, making it a hopeful candidate for further development as a therapeutic agent against Alzheimer’s.